MRI Heterogeneity Map Predicts Brain Metastasis Progression on EGFR Drugs
For patients with EGFR-mutant lung adenocarcinoma whose cancer has already spread to the brain, third-generation EGFR-TKI drugs such as osimertinib ...
For patients with EGFR-mutant lung adenocarcinoma whose cancer has already spread to the brain, third-generation EGFR-TKI drugs such as osimertinib ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine